Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Center Emergency Preparedness Policy Team Includes Gill, Pellerite

This article was originally published in The Gray Sheet

Executive Summary

CDRH Acting Deputy Director for Science Lillian Gill will lead the center's policy development team for emergency preparedness. The group will develop procedures for the center to follow in responding to a terrorist attack

You may also be interested in...



FDA Weighing Device Industry Survey For Emergency Response Data

FDA's Center for Devices & Radiological Health is considering creating a list of medical device manufacturers to be contacted in case supply shortages result from a bioterrorist attack

FDA Weighing Device Industry Survey For Emergency Response Data

FDA's Center for Devices & Radiological Health is considering creating a list of medical device manufacturers to be contacted in case supply shortages result from a bioterrorist attack

FDA Should Speed Waiver Process For Lot Release Tests During Emergencies

The Federal Office of Homeland Security should coordinate the distribution of diagnostic equipment and other blood testing products during emergencies, according to Johnson & Johnson/Ortho-Clinical Diagnostics' Director of Reimbursement and Health Policy Susan Reardon

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel